Citius Oncology (CTOR) Cash from Operations Growth (1y) (2024)

Citius Oncology (CTOR) Cash from Operations Growth (1y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 61.90%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -22.14%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.46%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 125.00%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 425.00%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -267.74%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 16.33%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -18.09%
10 Citius Oncology 75.12 Mn 72.49 Mn 1.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -265.17%
Mar 31, 2024 -13.56%